Sulzer AG Earnings Call: Record Margins Amid Headwinds

Sulzer AG ((CH:SUN)) has held its Q4 earnings call. Read on for the main highlights of the call.

Sulzer AG’s latest earnings call struck a generally upbeat tone, with management celebrating record profitability, expanding margins, and robust growth in core Flow and Services businesses. Still, investors were reminded of notable challenges, including Chemtech’s sharp downturn, FX headwinds, and timing risks as large projects shift into 2026, clouding near-term visibility.

Record Profitability and Margin Expansion

Sulzer reported record EBITDA of CHF 556 million, despite a CHF 40 million currency drag that would have lifted the figure close to CHF 600 million on a constant FX basis. The EBITDA margin reached about 15.6%, and management now targets a further step-up to roughly 16.5% by 2026, underscoring confidence in operational leverage.

Solid Sales Growth and Healthy Order Dynamics

Sales increased around 5.6% year over year, while order intake grew about 2.1%, signaling continued top-line momentum even in a mixed macro backdrop. A book-to-bill ratio of 1.06 shows orders still outpacing sales, supporting a growing backlog and providing a cushion for future revenue.

EPS Surge and Better Capital Efficiency

Earnings per share climbed 19%, pointing to strong bottom-line execution alongside the higher operating profitability. Return on capital employed improved by 140 basis points, indicating Sulzer is extracting more value from its asset base and investment decisions.

Flow Division Delivers Double-Digit Growth

The Flow division stood out as a key growth engine, with sales up 12.3% and EBITDA margin expanding by about 160 basis points to 13.3%. Energy business unit sales jumped more than 20% and Water also posted double-digit growth, culminating in an 18% year-on-year uplift for Flow in the fourth quarter.

Aftermarket Services Drive Resilient Revenue Mix

Services and aftermarket activities now account for roughly 62% of Sulzer’s turnover, having delivered double-digit growth for three consecutive years. EBITDA in Services rose by about 150 basis points, helped by targeted capacity and geographic investments in Argentina, Bahrain, and an expanded U.S. turbomachinery center to capture rising demand.

Robust Balance Sheet and Market Performance

Sulzer ended the period with cash and cash equivalents of around CHF 640 million and net debt of CHF 555 million, keeping net debt to EBITDA at about 1.0x. The company’s market capitalization has surged since 2023, translating into a total shareholder return of roughly 121%, far outpacing the SPI’s 33%.

Higher Dividend Underscores Confidence

Management proposed raising the dividend by CHF 0.50 to CHF 4.75 per share, implying a payout ratio near 50% that sits comfortably within the 40–70% target range. Cumulatively, dividend growth has been materially higher in recent years, signaling sustained confidence in cash generation and earnings quality.

Operational Excellence and Strategic Investments

Sulzer is accelerating its Sulzer Excellence program, backing it with investments in sales capabilities, commercial processes, and supply chain improvements that have boosted on-time delivery, quality, and safety. The firm also launched a Global Water Treatment Center of Excellence and created shared business hubs in Mexico, Madrid, Pune, and Suzhou to streamline operations.

Chemtech Under Pressure Amid Industry Weakness

Chemtech remains a problem area, with sales dropping 13.6% and EBITDA margin slipping by around 2 percentage points. Management pointed to overcapacity in refining, particularly in China, and subdued sentiment in the broader chemical industry as the main factors weighing on the division.

Project Delays Create 2026 Timing Risks

Heightened geopolitical volatility and customer caution caused substantial delays in large projects, with about 80% of major contracts originally expected in 2025 now pushed into 2026. This shift creates a muted outlook for the first half of 2026 and raises concentration risk in the second half as execution becomes more back-end loaded.

Severe FX Headwinds Distort Reported Results

A strong Swiss franc had a sizable negative translation impact, reducing reported order intake and sales by about CHF 190 million and cutting EBITDA by roughly CHF 40 million. Management noted EBIT would have been around CHF 36 million higher absent these currency effects, underlining the scale of FX pressure on the reported figures.

Cash Flow Shortfall and Chemtech Drag

Free cash flow ended around CHF 22 million below prior expectations, largely because Chemtech generated no free cash flow amid restructuring and one-off items. Higher tax payments of about CHF 10 million and roughly CHF 7 million lower interest income also weighed on overall cash conversion.

Restructuring Costs and Workforce Cuts in Chemtech

To restore profitability in Chemtech, Sulzer is centralizing activities and cutting costs, including the dismissal of more than 200 manufacturing roles in China. These measures bring near-term execution costs and operational disruption but are aimed at structurally improving the division’s competitiveness.

Limited Visibility in a Geopolitically Uncertain World

Management repeatedly stressed low near-term visibility as geopolitical risks and regional tensions complicate customer decision-making. As a result, Sulzer issued conservative guidance, projecting order intake growth of 1–5% and sales growth of 2–5% while deliberately excluding some large pipeline projects from its planning base.

Guidance: Conservative Yet Underpinned by Strong Core

For 2026, Sulzer guides to order intake growth of 1–5%, sales growth of 2–5%, and an EBITDA margin around 16.5%, assuming a subdued first half and stronger second half as delayed projects begin to land. The outlook bakes in currency headwinds and assumes continued strength in Flow and Services, gradual improvement in Chemtech, and sustained balance-sheet and dividend resilience.

Sulzer’s earnings call painted a picture of a company enjoying record margins and strong aftermarket and Flow growth, yet navigating real challenges in Chemtech, cash flow, and project timing. For investors, the story is one of solid underlying momentum backed by a strong balance sheet and rising dividends, but framed by cautious guidance and elevated execution risk into 2026.